- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
March 18, 2024Robins Kaplan Named Minnesota Firm of The Year by Benchmark Litigation
-
March 12, 2024Anthony Froio Elected Chair of Executive Board and Managing Partner of Robins Kaplan
-
March 12, 2024Robins Kaplan Recognized in 2024 World Trademark Review 1000
-
March 17-20, 2024PLRB 2024 Claims Conference
-
March 26, 2024Generative AI Generates Debate
-
May 2-3, 2024ACI Advanced Forum on Managed Care Disputes and Litigation
-
March 2024Do We Have to Share That Information? Attorney-Client Privilege in the Multi-Entity Context
-
March 2024Sellers of a Business: Know Thyself.
-
March 2024Unintended Consequences: Don’t Forget the Litigation Risks When Getting a Deal Done
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Obtained Summary Judgment for Biotechnology Manufacturer in Patent Litigation Relating to DNA Fingerprinting Technology
June 20, 2013
Promega Corporation v. Applied Biosystems, LLC, Life Technologies Corporation, and California Institute of Technology (N.D. Ill.)
On behalf of biotechnology manufacturer Promega Corporation, Robins Kaplan LLP obtained summary judgment of invalidity of all asserted claims—a complete victory for our client—in patent litigation relating to DNA fingerprinting technology. In the case before the U.S. District Court for the Northern District of Illinois, Promega prevailed in its arguments that the claims of U.S. Patent No. RE43,096, asserted against Promega, were invalid, in part due to the breadth of the claim constructions that defendants sought and obtained. On appeal, six days after oral argument, the district court decision was summarily affirmed by the Federal Circuit.
Related Professionals
Similar Results
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.